ArticleExperimental & molecular medicine2022

The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability.

Qianqian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.